Covered recipient · General Payments record
KARAN ANN KORTLANDER
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$2,384.35
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,548.75 | 1 |
| Food and Beverage | $171.17 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MERZ NORTH AMERICA, INC. | $1,548.75 | 1 |
| ABBVIE INC. | $89.67 | 4 |
| REVANCE THERAPEUTICS, INC. | $81.50 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.53 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104100724 | CMS |
| ABBVIE INC. | $21.66 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104100726 | CMS |
| ABBVIE INC. | $19.63 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104100728 | CMS |
| ABBVIE INC. | $28.85 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104100730 | CMS |
| MERZ NORTH AMERICA, INC. | $1,548.75 | 10/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1146386077 | CMS |
| REVANCE THERAPEUTICS, INC. | $24.58 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147944007 | CMS |
| REVANCE THERAPEUTICS, INC. | $23.38 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147944009 | CMS |
| REVANCE THERAPEUTICS, INC. | $13.57 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147944011 | CMS |
| REVANCE THERAPEUTICS, INC. | $19.97 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147944013 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.